Correlation Between Ikena Oncology and Lyell Immunopharma
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Lyell Immunopharma, you can compare the effects of market volatilities on Ikena Oncology and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Lyell Immunopharma.
Diversification Opportunities for Ikena Oncology and Lyell Immunopharma
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ikena and Lyell is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Lyell Immunopharma go up and down completely randomly.
Pair Corralation between Ikena Oncology and Lyell Immunopharma
Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.93 times more return on investment than Lyell Immunopharma. However, Ikena Oncology is 1.07 times less risky than Lyell Immunopharma. It trades about 0.02 of its potential returns per unit of risk. Lyell Immunopharma is currently generating about -0.01 per unit of risk. If you would invest 289.00 in Ikena Oncology on August 30, 2024 and sell it today you would lose (120.00) from holding Ikena Oncology or give up 41.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. Lyell Immunopharma
Performance |
| Timeline |
| Ikena Oncology |
| Lyell Immunopharma |
Ikena Oncology and Lyell Immunopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Lyell Immunopharma
The main advantage of trading using opposite Ikena Oncology and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Eliem Therapeutics |
| Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |